Source: Streetwise Reports 09/12/2022 One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving...
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Numinus Wellness Inc. (TSX: NUMI | OTCQX: NUMIF) is pleased to provide an update on the integration of the Novamind acquisition, which completed on June...
Revitalist Lifestyle and Wellness LTD (CSE: CALM | OTCQB: RVLWF | FSE: 4DO), Revitalist and Wake Network, Inc. will now be jointly offering ketamine infusions...
Psychedelics are known for encouraging the exploration of the subconscious, but what about the unconscious? Since the beginning of discussions about psychedelics...
The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal The post FDA starts review of first drug...
Psychedelics are known for encouraging the exploration of the subconscious, but what about the unconscious? Since the beginning of discussions about psychedelics...
The article Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study was originally published on Microdose. For more on Algernon and their DMT...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW0 | OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that...